Filing Details
- Accession Number:
- 0000950170-24-128558
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-19 16:05:05
- Reporting Period:
- 2024-11-18
- Accepted Time:
- 2024-11-19 16:05:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1422143 | Kura Oncology Inc. | KURA | Pharmaceutical Preparations (2834) | 611547851 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1785406 | Kathleen Ford | C/O Kura Oncology, Inc. 12730 High Bluff Drive, Suite 400 San Diego CA 92130 | Chief Operating Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-11-18 | 526 | $16.03 | 23,184 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- 526 shares were acquired on November 17, 2024 pursuant to the Issuer's Employee Stock Purchase Plan.
- This transaction was executed in multiple trades at prices ranging from $15.78 to $16.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Includes 1,582 shares acquired on May 17, 2024 pursuant to the Issuer's Employee Stock Purchase Plan.
Billionaire Hedge Funds
